Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians.

scientific article published on 30 August 2016

Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/INFDIS/JIW407
P932PMC publication ID5091372
P698PubMed publication ID27578850

P50authorMarcelo U. FerreiraQ55033395
P2093author name stringChristopher L King
Susana Barbosa
Vanessa C Nicolete
Sarah Frischmann
P2860cites workA Receptor for the Malarial Parasite Plasmodium vivax : the Erythrocyte Chemokine ReceptorQ24310519
Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding proteinQ28471832
The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysisQ33526349
Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean childrenQ33530114
Naturally acquired antibodies to Plasmodium vivax Duffy binding protein (DBP) in Brazilian AmazonQ33617528
Epidemiology of disappearing Plasmodium vivax malaria: a case study in rural AmazoniaQ34104487
Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysisQ34234390
Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malariaQ34236565
B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian AmazonQ34726966
Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding proteinQ34994491
Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individualsQ35606249
Analysis for genotyping Duffy blood group in inhabitants of Sudan, the fourth cataract of the NileQ36032160
Cytokine balance in human malaria: does Plasmodium vivax elicit more inflammatory responses than Plasmodium falciparum?Q36207389
Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth CohortQ36555103
Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infectionQ36751523
Red blood cell polymorphism and susceptibility to Plasmodium vivaxQ37058815
Naturally acquired immune responses to P. vivax merozoite surface protein 3α and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean childrenQ37308698
Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean childrenQ37333369
Insights into the naturally acquired immune response to Plasmodium vivax malariaQ38728598
Age-dependent acquisition of protective immunity to malaria in riverine populations of the Amazon Basin of BrazilQ39156102
Genetic diversity of Plasmodium vivax over time and space: a community-based study in rural AmazoniaQ42203394
A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1.Q42581710
Proportional hazards model with random effectsQ45301860
Malaria on the Amazonian frontier: transmission dynamics, risk factors, spatial distribution, and prospects for control.Q47879857
Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax duffy-binding proteinQ47880785
High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populationsQ47911926
Development of quantitative receptor-ligand binding assay for use as a tool to estimate immune responses against Plasmodium vivax Duffy binding protein Region II.Q48019458
The pattern of major polymorphisms in the Duffy binding protein ligand domain among Plasmodium vivax isolates from the Brazilian Amazon areaQ48021635
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectmalariaQ12156
antibodyQ79460
Plasmodium vivaxQ311376
P304page(s)1539-1546
P577publication date2016-08-30
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleNaturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians
P478volume214